Back to results
US 2023/0414522 A1Published application
Talazoparib soft gelatin capsule dosage form
AssigneePfizer Inc.
InventorsAlan Francis CARMODY, Lydie Claude Sylvie PAIRET
Life of this patent
Estimating the term…
Abstract
A pharmaceutical soft gelatin capsule dosage form comprising a soft gelatin shell and a fill, wherein: (a) the soft gelatin shell comprises gelatin and at least one plasticizer; and (b) the fill comprises an anti-oxidant, at least one solvent, and talazoparib or a pharmaceutically acceptable salt thereof. Said pharmaceutical composition for use in treating cancer.
Claims22
A pharmaceutical soft gelatin capsule dosage form comprising a soft gelatin shell and a fill, wherein:
- (a) the soft gelatin shell comprises gelatin and at least one plasticizer;
- and
- (b) the fill comprises an anti-oxidant, at least one solvent, and talazoparib or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.